Evidence-based articles on biohacking, AI research and substances — anchored in real scientific studies.
Active Recovery (light training after a workout) can improve muscle soreness, pain perception, and perceived recovery for many people, but effects are not always consistent. The evidence base is mostly RCT-based, with heterogeneous protocols. Lifestyle levers such as sleep, training load management, and nutrition remain the most important levers.
Cold Exposure can affect mood, stress responses, or affective state in the short term for some people, but the evidence strength varies across target populations. There are meta-analyses and RCTs for psychological endpoints; however, protocols are often heterogeneous, follow-up is frequently short, and measurement outcomes are not uniform.
GABA supplements show limited, not consistently reproducible evidence across randomized trials, depending on the target domain. For sleep, stress, or cognition, benefits appear in some studies but not clearly in others. Sleep, exercise, light exposure, and stress-management strategies remain central. Overall, the data on dosing and safety are limited.
Training intensity measurably affects performance capacity, fat mass, and cardiovascular health—especially when higher intensities are combined with sufficient volume. Evidence is strong for endurance and mixed for strength/muscle retention. Results generally reflect group averages; individual responses vary. There is no universal “best” intensity.
For depression, robust evidence exists mainly for psychotherapy, antidepressants (depending on diagnosis/severity), and lifestyle interventions such as exercise, sleep, and light. Effect sizes vary from study to study. Add-ons are usually only limitedly supported. The evidence base ranges from meta-analyses to animal studies—the differences matter.
Maximal strength is trained primarily through progressive resistance exercise; in RCTs and meta-analyses, the outcome measures and effects are generally quantifiable. For add-on methods (e.g., supplements, recovery aids), the evidence is often weaker or depends strongly on context and study conditions. Here, we separate evidence from speculation—briefly and grounded in studies.
EAAs (complete essential amino acids) and BCAAs (leucine, isoleucine, valine) can support muscle protein synthesis and recovery—especially when dietary protein intake is insufficient. For sports performance, effects are variable and highly context-dependent. The evidence base is heterogeneous; safety is usually unremarkable at typical amounts, but data on long-term outcomes are limited.
Pneumatic Recovery (NormaTec) can improve some people’s perceived recovery after exertion. The evidence base mainly includes RCTs on athletic performance and recovery, but device protocols vary substantially. Clear statements about long-term effects and safety are often limited by inconsistent study design and insufficiently robust effect sizes.
EMDR/trauma therapy can be effective for many groups; the strongest data come from randomized controlled trials and meta-analyses. Still, effect sizes vary depending on the trauma type, the comparison group, and the measurement tool. This post breaks down what is robustly supported, where the evidence fluctuates, and how to judge study quality.
Zinc can help when a deficiency is documented and in specific situations (e.g., the duration of a cold). For many “longevity” claims, the evidence is weak or inconsistent. What matters is the evidence level (meta-analysis/RCT), baseline context: diet/sleep/infection risk, and dosing including upper limits and interactions with iron/Cu.
Based on the current state of research, whey and casein mainly support muscle gain or maintenance by providing essential amino acids—especially **leucine**. The RCT evidence for measurable effects alongside resistance training is strongest. By contrast, many conclusions about “longevity” and “fat loss” are limited in scope.
SAMe is most often studied for depression and, to some extent, for osteoarthritis. Systematic reviews and meta-analyses generally report favorable effects, but the overall data quality varies. For other “CNS/health” claims, evidence is thinner. Safety: possible side effects; relevant caution with depression and medication interactions; prioritize lifestyle levers first.
The evidence base on alcohol is clear: for treating alcohol use disorders, multiple meta-analyses exist for medications such as naltrexone, acamprosate, nalmefene, baclofen, and topiramate. For health effects of alcohol outside addiction treatment, the evidence is heterogeneous. Lifestyle levers (sleep, movement, stress management, substitution/structure) are often the first step before supplements.
HbA1c reflects average blood glucose over the past weeks and is central for diagnosing and monitoring diabetes. For clinical decisions, HbA1c is established in guidelines; links to complications (e.g., retinopathy, kidney disease) are plausible based on meta-analyses. Data on HbA1c variability are also growing, but not consistently strong across outcomes.
Sauna can affect blood pressure and circulation markers in the short term, and for people with cardiovascular disease it may be safer than uncontrolled heat exposure, but the data is strongest for specific endpoints. For “recovery” in the sense of sports performance/fitness improvement, effects are sometimes indirect and the methods across studies vary.
Semaglutide is well supported for weight loss in people with obesity/overweight, with multiple meta-analyses and systematic reviews. For safety, current pooled analyses exist, but side effects depend on both dose and the individual patient. Meta-data from RCTs also covers cardiovascular effects, though the details vary by population and endpoint.
Magnesium may improve sleep quality in some people, but the evidence is not consistent and depends strongly on baseline factors (e.g., deficiency). Meta-analyses support some effects, but not all outcomes. For better results, prioritize sleep, light, movement, and nutrition; magnesium remains a supplemental lever.
In studies, yoga shows benefits mainly for stress and stress-related markers, as well as certain pain and osteoarthritis outcomes. For sleep and cardiovascular parameters, the evidence is promising but sometimes based on small or narrowly designed studies. Methodologically, the data are heterogeneous: study formats, duration, and primary endpoints differ substantially.
Tirzepatide has shown effectiveness in multiple randomized trials (RCTs) for the treatment of type 2 diabetes and for weight reduction; effects are dose-dependent and comparatively well quantified. However, data on long-term outcomes outside clearly defined indications are limited, and safety considerations require careful risk–benefit assessment with medical supervision.
Selenium may show targeted effects on specific metabolic and immune markers depending on your starting status (low selenium vs. adequate intake). However, for many claimed “longevity” or performance benefits, the data is inconsistent or limited. Supplementation is dose-dependent: taking too much can be harmful.
Vitamin B-complex is mainly useful when there is a deficiency or when specific risk groups are affected (e.g., elevated homocysteine levels). Many effects outside deficiency states are inconsistent or only weakly supported in RCTs. Key takeaway: lifestyle (diet, sleep, alcohol) before supplements.
For the post-workout window, the best-supported levers are nutrition (protein amount; carbohydrates if needed), sufficient total daily protein, and sleep. Many “hacks” have limited data. We rank 11 high-quality studies by strength of evidence, name measurable effects, and clarify where research is missing or results are inconsistent.
Recovery Nutrition likely helps mainly through timing and appropriate macronutrients after exercise (e.g., protein for muscle protein synthesis, carbohydrates for glycogen replenishment), while many “extra” claims are only weakly supported. The strongest evidence comes from RCTs and meta-analyses on protein and carbohydrates—especially when combined with adequate overall energy balance and sleep.
Nootropic Stacks are often blends without robust validation data. For individual ingredients, there may be RCTs depending on the substance, but high-quality studies for the “stack” combinations are usually missing. Prioritize sleep, movement, light, and nutrition; supplements can complement, but only when the target effect is supported and safety information is clear.
Blue light demonstrably influences wakefulness via the light input to the visual system and can worsen sleep when used at the wrong time. Evidence for broad health outcomes is inconsistent depending on the endpoint. We classify RCTs, meta-analyses, and observational studies—plus practical, supplement-free steps—into what is more or less solid.
Sleep tracking can help you understand sleep patterns, but accuracy for individual parameters on consumer devices is limited. Systematic reviews show valid results mainly in group comparisons versus polysomnography, with measurement scatter. For better sleep quality, lifestyle changes—and for insomnia, behavior therapy—remain central.
Increasing telomere lengths is only plausibly achievable with a few approaches that have reasonably good evidence. Meta-analyses suggest measurable effects mainly for movement/exercise, lifestyle interventions, and—sometimes—social support, but these effects are usually small. For “ALT/other” telomere mechanisms there are signals, but they are primarily relevant in tumor contexts.
Tendon health improves more reliably when you optimize load, movement, body weight, sleep, and recovery first. The strongest evidence level comes from training and rehabilitation approaches; much of the supplement evidence is limited. What matters most is which tendon problem you have and whether the data come from RCTs, observational studies, or animal research.
“Sleep as Recovery” is plausible as a concept, but the evidence differs: for specific interventions there are meta-analyses (e.g., sleep restriction, melatonin, movement formats, and sometimes hypnotics). However, the data are often for single endpoints such as sleep quality rather than direct “recovery” of other systems. Lifestyle levers have priority over substances.
Sulforaphane are often marketed for health effects, but the evidence quality varies strongly by endpoint. For robust claims, you need large, well-designed RCTs or meta-analyses; for many statements, the data is limited. Lifestyle levers like activity, sleep, and diet are usually the stronger “switches” to focus on first.
Load Management means steering training/treatment burden so symptoms decrease without increasing risk. The studies used here are mainly meta-analyses and systematic reviews of load-adjacent therapeutic concepts (e.g., shoulder/back pain). The evidence is strongly dependent on study design and analysis choices.
HIIT improves measurable fitness and performance markers in many meta-analyses, especially cardiovascular performance (VO2max/CRF). For cognition, there are also positive effects in reviews, but findings depend more strongly on study design and population. The optimal dose and best protocol aren’t “one size fits all.” Side effects/risks depend on baseline status and how training is programmed.
Sleep onset latency is usually influenced most strongly by behavior-adjacent factors (sleep hygiene, light/timing, movement). For supplements, the evidence base varies by substance: melatonin often shows effects, while other options—including trazodone—must be judged by their specific benefit–risk profiles as evaluated in studies. Evidence for many “tricks” is limited.
Cold therapy (e.g., cryotherapy chamber or cold-water immersion) is often marketed for recovery and performance goals, but the evidence for clear, clinically meaningful effects is inconsistent. This overview categorizes evidence by study design, highlights common analysis pitfalls, and explains what is currently supported—and what remains open.
Microbiome modulation often sounds straightforward, but effects are heterogeneous: outcomes depend strongly on baseline status, the intervention, and study design. This overview organizes RCTs, observational studies, and animal data—and explains why many nutrition meta-analyses are methodologically shaky. You’ll learn how to identify robust evidence rather than plausible-sounding assumptions.
Breathwork can improve stress, mood, and physiological arousal in randomized studies and may be helpful for certain breathing- and pain-related topics. Meta-analyses support effects most consistently for stress/mental health and related indications. However, for specific breathing techniques, dose, and long-term safety, the data are sometimes still inconsistent.
Compression Recovery can partly improve DOMS and measurable recovery, but effects vary by outcome and study design. Meta-analyses repeatedly show benefits, especially for delayed-onset muscle soreness (DOMS), yet there is no universal “miracle effect.” Proprioception and performance improve only in specific situations; safety is generally well covered in the available data.
Cortisol can be influenced through lifestyle, but “lowering cortisol” is not automatically the same as “being healthier.” The evidence depends heavily on how cortisol is measured and on study design. Use an evidence hierarchy (RCTs before observational work), assess the risk of bias, and limit your conclusions when data are limited.
Sleep cycles are often marketed as an “optimization lever,” but the underlying, robust evidence depends heavily on study design. This overview ranks the evidence, explains the limits of meta-analyses (models, error sources), and clarifies what cannot be safely inferred without solid primary data.
In studies, binaural beats and sound therapy can affect cognition, stress, and sometimes tinnitus, but the strength of the evidence varies by endpoint. One meta-analysis supports benefits for cognition/anxiety/pain, while additional RCTs in tinnitus show mixed results, often with combined approaches. Safety data is limited.
Intermittent fasting is in meta-analyses usually associated with measurable improvements in weight and some metabolic markers. For type-2 diabetes, the data show short-term effects that sometimes fade after stopping. For preventing cardiovascular disease, results are more indirect, and evidence quality varies.
Bacopa monnieri is studied mainly for memory and other cognitive endpoints. In a meta-analysis of randomized studies, there are indications of cognitive effects, but the magnitude depends strongly on the study design and the endpoints used. Newer reviews also summarize safety data; however, robust dose and bioavailability guidance is limited.
A ketogenic diet can improve weight loss, blood sugar and triglyceride levels, and reduce seizure frequency in certain epilepsy forms. For many other goals, effects are smaller or the data is inconsistent. The evidence strongly depends on study design, target population, and study duration; lifestyle fundamentals are often the more decisive factor.
The best evidence for better insulin sensitivity comes from weight loss, higher fiber intake, fewer highly processed carbohydrates, and an overall lower-energy diet. Effects are usually moderate and depend heavily on starting weight, calorie balance, and adherence. For many supplements, the data are much weaker than for nutrition and lifestyle.
NAD+ precursors such as NMN and NR often raise NAD+-related markers in human studies, but clinical benefits remain inconsistent and usually small. For sleep, longevity, or clear performance gains, the current evidence is insufficient. Safety looks acceptable in studies overall, but long-term data and clear benefit signals are still lacking.
Creatine Monohydrate is one of the best-studied supplements: the evidence supports better short-term performance and more strength or lean mass, especially when combined with training. For endurance, the benefit is smaller and less consistent. Safety data are overall reassuring, but caution is needed in kidney disease.
Omega-3 fatty acids are biologically plausible and well studied, but their effects depend heavily on the goal, the dose, and the form. For cardiovascular prevention, the data are mixed; for broad “health” claims, the evidence is clearly weaker. Sleep, diet, and fish intake are more important levers than supplements.
Melatonin is not a strong sleeping pill, but in several meta-analyses it can moderately shorten sleep-onset latency, especially for jet lag, shift work, and delayed sleep phase. The best foundation remains sleep hygiene, light control, and consistent timing; with supplements, lower doses are often more sensible than higher ones.
Caffeine + L-Theanine can improve alertness, attention, and subjective “nervousness” under caffeine in studies, but the evidence is overall small to moderate and strongly dependent on dosage, task type, and caffeine amount. Sleep, caffeine timing, and total intake remain more important than the supplement itself.
HRV Biofeedback can reduce stress markers in studies and influence the autonomic nervous system, especially as a complementary method. The evidence is strongest for stress, anxiety, and some pain-related endpoints; for many other goals it remains limited. First optimize sleep, movement, light, and breathing, then Biofeedback.
Magnesium is an essential mineral, but the evidence for noticeable added benefits in healthy people is limited. Its best-supported use is correcting a deficiency; evidence for blood pressure, migraine, and cramps is only partial. Before supplements, sleep, diet, and identifying causes come first.
Vitamin optimization makes the most sense when a deficiency is present or the risk is high. For healthy people without a deficiency, the benefit of supplements is usually small or unproven. Priority should go to nutrition, sunlight, movement, and sleep; lab values and medical evaluation should come before high-dose products.
The three best-known sleep books emphasize different things: Walker explains sleep in a popular way, Foster frames chronobiology, and Littlehales provides practical guidance for everyday life and sport. For readers, the key point is that Walker’s mortality claims were publicly criticized; the most robust data concern sleep duration, regularity, and light.
The best-supported 30-minute morning routine starts with bright daylight, then short movement, fluids, and only later caffeine. Light stabilizes the body clock, movement increases alertness, and delaying caffeine may protect sleep. The evidence is strongest for light, while electrolytes and some timing details remain mixed.
In PCOS, Inositol — especially Myo-Inositol — may improve ovulation, hormone values, and some metabolic parameters according to meta-analyses. In direct comparison with Metformin, the effects are often similar, but the studies are heterogeneous and in some cases small. Lifestyle remains the foundation; data on safety and long-term benefit are still limited.
The well-known Kuopio cohort found, in observational data, lower cardiovascular and all-cause mortality with more frequent sauna use; 4–7 sessions per week performed better than 2–3. But this is not proof of causality. The studies mostly used 15–20 minutes at about 80–100 °C, with cooling breaks as tolerated.
Before supplements, prioritize sleep hygiene, morning light, movement, and enough fluids. For magnesium, the evidence for direct sleep effects is overall thin; the best data for magnesium are in people with low status. Glycine 3 g before bed has been studied in small RCTs with better subjective sleep quality and less daytime sleepiness, but the studies are small.
At biohacking conferences, targeted conversations with speakers, coaches, and industry contacts bring more value than random small talk. Clear goals, good preparation, short openings, active listening, and clean follow-up within 24 hours work best. Evidence on networking itself is mostly observational, not experimental.
Many free online summits are primarily marketing funnels with backend sales; they are only worthwhile in terms of content when they provide clear evidence, independent speakers, and transparent sponsors. Because screen time has been shown to worsen sleep quality, the practical value is often good only when you choose sessions deliberately and do not keep consuming until sleep suffers.
Longevity Day Munich shows one thing above all: German longevity research in 2026 is strong in basic science, biomarker, and prevention questions, but clinical endpoints are often still rare. For readers, sleep, movement, nutrition, and light come first; supplements and anti-aging interventions are usually much less well supported.
The Biohacker Summit Helsinki 2026 is especially relevant for DACH biohackers if they are looking for evidence-aligned talks, practical relevance, and a Scandinavian biohacking perspective. In this article, we classify speakers, topics, travel value, ticket questions, and the evidence hierarchy so you can separate marketing from reliable content.
The Health Optimisation Summit Berlin is especially worthwhile for readers looking for concrete contacts, new perspectives, and curated content; as a pure source of knowledge, the talks do not replace systematic evidence review. Its biggest value usually lies in networking, selected workshops, and orientation on which trends are actually supported by solid evidence.
Biohacking is not a catch-all term for miracle remedies, but a mix of measurement, lifestyle, and targeted interventions. If you understand the key terms such as HRV, ApoB, RCT, Zone 2, Cohen-d, NMN, and RED-S, you can classify studies better, spot marketing faster, and prioritize measures sensibly: sleep, movement, and nutrition before supplements.
Training, nutrition and recovery can be adapted to the female cycle, but the effects are usually small to moderate and highly individual. The most consistent pattern is: place harder sessions more often in the follicular phase, plan for a higher subjective load in the luteal phase, prioritize sleep and energy intake, and avoid overestimating the evidence.
In perimenopause, the strongest levers are not supplements, but strength training, sufficient protein, sleep, movement, and bone protection. For hormone replacement therapy, the key is individual assessment, especially with troublesome symptoms; the evidence from KEEPS and ELITE suggests a more favorable start in early menopause, not a blanket recommendation.
Ferritin is a storage-iron marker, and in women values below 50 ng/ml can be associated with fatigue, reduced performance, and hair loss even with normal Hb. Standard primary-care tests often miss early deficiencies; ferritin, blood count, and inflammatory markers are needed for interpretation. Iron should only be supplemented after diagnosis, because overdose and incorrect self-treatment carry risks.
Biohacking is mainly useful for healthy adults interested in sleep, movement, nutrition, and self-observation. You should not start, or should only do so with medical supervision, during pregnancy, with severe illness, a history of eating disorders, as a minor, or with risky experiments involving sleep, fasting, or stimulants. The benefit depends heavily on the method, goal, and evidence base.
Zone-2 cardio is usually the intensity just below the first lactate threshold, where you can still speak in full sentences. The 150–180 minutes per week range is a practical target, but it is not exactly proven. The best approach is talk test plus heart rate, not a single number.
Directly after strength training, Cold Plunge can blunt hypertrophy and strength adaptation if muscle gain is the goal; several RCTs and reviews show this. For competition season, tightly scheduled multiple sessions, or acute pain reduction, it can be useful, ideally not directly after the workout.
“Lifespan” is not a scam, but it is also not proof of an anti-aging program. The strongest evidence is for basic biology around NAD+ and sirtuins; for NMN in humans, the data are still small and short. Lifestyle levers remain more relevant than supplements, and Sinclair’s roles at Sirtris and InsideTracker make a critical reading necessary.
“Roar” is primarily intended for menstruating athletes, while “Next Level” is for women in perimenopause and menopause. The practical difference is less about “more biohacking” than about the hormonal phase, the nutritional recommendations, and the training focus. The evidence for many specific book claims is partly limited and not always directly supported by RCTs.
“Outlive” is not a supplement book, but a priority plan: first sleep, movement, nutrition, and strength, then blood markers such as ApoB and metabolic markers. Attia’s core point is to lower risk factors early, because prevention comes before symptom treatment. For Rapamycin and other longevity approaches, the human data are still limited.
Evidence-based biohacking separates interventions by study signal, effect size, and risk: sleep, movement, light, and nutrition first, then supplements only when the data are solid. Wellness trends often offer plausibility instead of proof. The key is controlled studies, reproducibility, and clear limits of the evidence.
Biohacking means deliberately changing sleep, movement, light, nutrition, or technology to improve health or performance. Quantified Self is first about measurement: collecting data, recognizing patterns, understanding behavior. The two fields overlap, but they are not the same.
Rapamycin extends lifespan in several mouse models, but hard endpoint data on longevity are still missing for healthy humans. The current human evidence consists mainly of reviews, one observational study, and off-label practice reports. The data remain insufficient for benefit, dose, and long-term safety in humans.
Statins lower circulating CoQ10, but that does not automatically imply a clinically relevant deficiency. The evidence for CoQ10 in statin myalgias is mixed; for heart failure there are RCTs such as Q-SYMBIO, but with important limitations in blinding and generalizability. Ubichinol is more bioavailable, but the clinical advantage is not clearly proven.
Curcumin is pharmacokinetically difficult: unchanged Curcumin is only poorly detectable in the blood after oral intake. Piperin can markedly increase bioavailability in a widely cited human study, but it also carries interaction risks. Formulations such as Meriva, Theracurmin, or BCM-95 improve absorption, yet clinical benefits are not always shown to be proportional to higher blood concentrations.
Magnesium threonate is biologically plausible because it is supposed to reach the blood-brain barrier better, but the human evidence is still thin. There are small RCTs with hints of better cognitive measures and sleep, but the benefit is not securely established. For sleep, sleep hygiene, light, and movement come first; among supplements, the evidence for magnesium overall is stronger than for threonate specifically.
Resveratrol is interesting in mouse and mechanistic studies, but for human longevity endpoints there is currently no convincing RCT evidence. The oft-cited sirtuin story comes mainly from preclinical data; in human studies, effects are small, inconsistent, or dependent on baseline status. Anyone aiming to optimize health should first address sleep, movement, nutrition, and light.
Lion’s Mane (Hericium erinaceus) has a plausible biological basis, but the human evidence for cognition is still weak: there are only small, short RCTs, while mechanisms such as NGF come mainly from cell and animal studies. For healthy adults, a clear cognitive benefit is not proven; much remains open on dose and safety.
HRV is most useful as a trend marker for recovery and stress, not as an exact health value. For biofeedback, resonant breathing at about 6 breaths per minute is well supported and can favorably influence HRV, blood pressure, and mood. Wearables like Oura or Whoop are better for longitudinal data than for absolute comparisons.
Vitamin K2 (especially MK-7) has shown small to moderate effects on bone markers and, in some trials, on bone density, particularly in postmenopausal women. For vascular or cardiovascular outcomes, the evidence is much weaker. The best foundation remains sleep, movement, nutrition, and adequate vitamin D; K2 is more of an add-on.
Ashwagandha shows moderate effects on stress, anxiety, and in some cases sleep quality in several randomized studies; for testosterone there are positive, but small and not universally generalizable RCTs. In practice: sleep, light, movement, and nutrition come first. Since 2023, Scandinavian liver safety warnings also deserve serious attention.
Cold immersion is not a miracle cure. For brown fat, there are signs of adaptation, but most data come from small human studies or animal models. For mood and recovery, the evidence is much thinner; robust effects, dose, and safety have not yet been clearly established.
Morning daylight is one of the most effective, lowest-cost interventions for the circadian rhythm: it shifts and stabilizes the internal clock, promotes evening melatonin release, and can improve daytime alertness in many people. The often-cited “1000 lux in the first hour” rule is practical, but the evidence is more complex than social-media shorthand suggests.
The Laukkanen studies are interesting observational data: more frequent sauna use was associated with lower all-cause, cardiovascular, and dementia mortality. But this does not prove causality, because lifestyle and health can also shape the results. RCTs are lacking; sauna is at most a plausible but unproven longevity lever.
L-Theanine plus caffeine is a sensible focus stack when sleep, light, and movement are already in place. In several RCTs, the combination improved attention and reaction time; a commonly used ratio is 1:2, for example 100 mg caffeine plus 200 mg L-Theanine. The evidence is moderate, not definitive.
Selenium can lower TPO antibodies in Hashimoto in several randomized studies, usually at 200 µg/day for 3–6 months. But the clinical benefit for symptoms is inconsistent. Before supplements, iodine status, sleep, nutrition, and thyroid medication matter more. Too much selenium can be harmful; high levels in the SELECT study signaled a higher diabetes risk.
Quercetin is a flavonoid with plausible effects on mast cells and allergic symptoms, but the clinical evidence is limited and often small. For hay fever, there are isolated positive but not robust studies; for exercise performance and antiviral effects, the data are mixed to limited. Bioavailability is a central problem.
NEAT is daily movement outside planned training and matters greatly for energy expenditure, health, and sedentary risk. Observational studies show: even more steps per day are associated with lower mortality, and in one large US analysis, about 4,400 steps/day was already more favorable than very low activity.
Creatine can improve strength performance in women; the evidence for bone density and cognition is much thinner and often context-dependent. The common dosage is broadly the same for women and men, usually 3–5 g daily. Water retention is possible, but it does not automatically mean fat gain or looking “puffy.”
Most randomized studies show: intermittent fasting is usually about as effective as classic calorie restriction for weight loss, but not clearly superior. For glucose, insulin, and other metabolic markers, the effects are small to moderate and strongly dependent on the comparison diet. Human evidence for autophagy remains thin; in women, menstrual disruption and overly aggressive fasting protocols should be taken seriously.
Breathing techniques can subjectively reduce stress, but the evidence varies widely by method. For Box Breathing and Buteyko, clinical data are limited; for the Wim Hof method, the endotoxin study by Kox et al. 2014 is important, but often overinterpreted. Hyperventilation carries real risks, including dizziness, fainting, and injury.
The biggest sleep-hygiene effects usually do not come from supplements, but from consistency: a fixed wake time, plenty of morning light, less bright light in the evening, a cool bedroom, caffeine early enough, and no alcohol as a sleep aid. The strength of the data varies by lever; the most robust evidence is for light, caffeine, and alcohol effects on sleep architecture, while some everyday rules are derived more from observations and mechanistic reasoning.
NMN, Nicotinamid-Ribosid (NR), and Nicotinamid can raise NAD+ markers in blood, but the clinical evidence for sleep, insulin sensitivity, or muscle function remains thin so far. The 2026 literature is clearly biomarker-heavy: good signals for NAD+ metabolites, but no robust data for hard endpoints, and the studies are heterogeneous in dose, duration, and population.
Semaglutide and Tirzepatide are among the most effective medications for weight loss; however, the long-term benefit depends heavily on whether treatment is continued and combined with nutrition, exercise, and sleep. After stopping, the risk of weight regain is relevant. Data on muscle mass loss are still limited, and lifestyle factors remain central to maintaining results.
Berberine can moderately lower blood sugar in people with type 2 diabetes and insulin resistance, but the data are heterogeneous and study quality is often limited. Reviews and meta-analyses usually show a small to medium effect on fasting blood glucose, HbA1c, and insulin resistance; direct comparisons with metformin exist, but they are short and methodologically limited. Priority should go to sleep, movement, weight loss, and diet; berberine is not a substitute for physician-managed therapy.